Abstract
In marked contrast to antibactieral chemotherapy there are very few agents available for the treatment of fungal infection. The reasons for this are mainly because the majority of fungal infections are not life-threatening to man, are far less common than bacterial infections, and, because they are eukaryotic pathogens, it is difficult to develop drugs which are specific for fungi without being concomitantly toxic to man. Because of these reasons the impetus for the development of new antifungal drugs is far less than that for antibacterials. However, the situation may change since fungal infection is increasing. This is due not only the increased use of broad-spectrum antibacterial antibiotics which enable fungi to infect secondarily, but also the use of corticosteroids and immunosuppressive drugs which produce the same effect.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
11.8 References and Further Reading
Andreoli, T. E. (1974). The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. Ann. N. Y. Acad. Sci., 235, 448–53
Cartwright, R. Y. (1974). Clotrimazole in the treatment of acute and ‘resistant’ vaginal candidiasis. Postgrad. med. J., 50, Suppl. 90–4
Cartwright, R. Y. (1975). Antifungal drugs. J. antimicrobial Chemotherapy, 1, 141–62
Clayton, Y. M. and Connor, B. L. (1973). Comparison of clotrimazole cream, Whitfield’s ointment and nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. Br. J. Dermatol., 89, 297–303
de Nollin, S., Van den Bossche, H. and Borgers, M. (1974). The ultrastructure of Candida albicans after in vitro treatment with miconazole. Saboraudia, 12, 341–51
Goldman, L. (1970). Griseofulvin. Med. Clin. North Am., 54, 1339–42
Grisham, L. M., Wilson, L. and Benson, K. G. (1973). Antimitotic action of griseofulvin does not involve disruption of microtubules. Nature, Lond., 224, 294–6
Gull, K. and Trinci, A. P. J. (1973). Griseofulvin inhibits fungal mitosis. Nature, Lond., 244, 292–4
Harold, F. M. Antimicrobial agents and membrane function. Adv. microbial Physiol., 4, 45–104
Harrison, E. F. and Zygmunt, W. A. (1974). Haloprigin: mode of action studies in Candida albicans. Can. J. Microbiol., 20, 1241–5
Hermans, P. E. (1977). Antifungal agents used for deep-seated mycotic infections. Mayo Clin. Proc., 52, 687–93
Holt, R. J. (1974a). Treatment of vulval candidiasis with 5-fluorocytosine. Br. med. J., iii, 523–4
Holt, R. J. (1974b). Recent developments in antimycotic chemotherapy. Infections, 2, 95–107
Kinsky, S. C., Luse, S. A. and Van Deeman, L. L. M. (1966). Interaction of polyenes antibiotics with natural and artificial membrane systems. Fed. Proc. Fedn Am. Socs exp. Biol., 25, 1503–8
Kinsky, S. C. (1967). Polyene antibiotics. In Antibiotics, Vol. 1 (D. Gottlieb and P. D. Shaw, eds). Springer-Verlag, Berlin, Heidelberg, New York, pp. 122–41
Kinsky, S. C. (1970). Antibiotic interactions with model membranes. A. Rev. Pharmacol., 10, 119–42
Kobayashi, G. S. and Medoff, G. (1977). Antifungal agents: recent developments. A. Rev. Microbiol., 31, 291–308
Lampen, J. O. (1968). Interference by polyenic antifungal antibiotics, especially nystatin and filipin with specific membrane functions. In Biochemical Studies of Antimicrobial Drugs (B. A. Newton and P. E. Reynolds eds). Cambridge University Press, London, pp. 111–30
Lampen, J. O., Arnow, P. M., Borowska, Z. and Laskin, A. L. (1962). Location and role of sterols at nystatin binding sites. J. Bact., 84, 1152–9
Male, O. (1974). A double-blind comparison of clotrimazole and tolnaftate therapy of superficial dermatophytoses. Postgrad. med. J., 50, Suppl., 75–7
Martin, J. F. (1977). Biosynthesis of polyene macrolide antibiotics. A. Rev. Microbiol., 31, 13–38
McGill, P. E., Sequeira, R., Jindani, A., Nguli, E. T., Forrester, A. T. T. and Fulton, W. F. M. (1969). 5-Fluorocytosine in the treatment of cryptococcal meningitis. East Afr. med. J., 46, 663–4
Polak, A. and Scholar, H. J. (1975). Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy, 21, 113–30
Scheef, W., Symoens, J., Van Camp, K., Daniels, R. and Deheeuw-Delvigne, R. (1974). Chemotherapy of candidiasis. Br. med. J., i, 78–80
Schönebeck, J. (1962). Studies on Candida infections of the urinary tract and on the antimycotic drug 5-fluorocytosine. Scand. J. Urol. Nephrol., Suppl. 11
Shadomy, S. and Wagner, G. E. (1975). Antifungal agents. A. Repts. med. Chem., 10, 120–30
Van den Bossche, H. (1974). Biochemical effects of miconazole on fungi. 1. Effects on the uptake and/or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicans. Biochem. Pharmacol., 23, 887–99
Van den Bossche, H., Willemsens, G., Cools, W., Lauwers, W. F. J. and Jenne, L. L. (1978). Inhibition of ergosterol biosynthesis on Candida albicans by miconazole. Curr. Chemotherapy, 1, 228–30
Voigt, W. H. and Plempel, M. (1974). Electron microscopic studies on human pathogenic fungi. 1. Ultrastructural changes produced by clotrimazole in Candida albicans cells in animal experiments. Arzneimit.-Forsch., 24, 508–15
Voigt, W. H. and Schnell, J. D. (1974). Electron microscopic studies on human pathogenic fungi. 2. Ultrastructural changes in Candida albicans cells in the human vaginal epithelium during treatment with clotrimazole. Arzneimit.-Forsch., 24, 516–23
Copyright information
© 1980 David Edwards
About this chapter
Cite this chapter
Edwards, D. (1980). Antifungal Agents. In: Antimicrobial Drug Action. Palgrave, London. https://doi.org/10.1007/978-1-349-16360-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-349-16360-1_11
Publisher Name: Palgrave, London
Print ISBN: 978-0-333-23568-3
Online ISBN: 978-1-349-16360-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)